Abstract
The prevalence rates of β-thalassemia (β-thal) and Sickle Cell Disease (SCD) in Saudi Arabia are considered one of the highest compared to surrounding countries in the Middle East (0.05% and 4.50%, respectively). In this study, Secondary data analysis was obtained from the premarital screening and genetic counseling program (PMSGC), and included 12,30,582 individuals from February 2011 to December 2015. Prevalence rates (per 1000 population) for β-thal and SCD were calculated for carrier status, disease status and their combination. During the 5-year study period, the overall prevalence rate per 1000 population for β-thal was 13.6 (12.9 for the trait and 0.7 for the disease). The prevalence rate for SCD was 49.6 (45.8 for the trait and 3.8 for the disease). Rates for β-thal were found to decrease from 24.2 in 2011, to 12 in 2015. However, SCD rates remained rather constant and ranged from 42.3 in 2011 to 49.8 in 2015. The highest rate for both β-thal and SCD was observed in the Eastern and Southern regions. This result reflects major accomplishment of the PMSGC. This study recommends further improvement in preventive measures in high-risk regions, and enhanced community awareness to provide the highest rate reduction for these disorders.
Article PDF
Avoid common mistakes on your manuscript.
References
Chatterjee T, Chakravarty A, Chakravarty S. Population screening and prevention strategies for thalassemias and other hemoglobinopathies of eastern India: Experience of 18,166 cases. Hemoglobin 2015;39(6):384–8. doi: https://doi.org/10.3109/03630269.2015.1068799.
Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull. World Health Organization 2001;79(8):704–12 [PubMed PMID: 11545326; PMCID: Pmc2566499].
Cao A, Rosatelli MC, Monni G, Galanello R. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 2002;29(2):305–28 [vi–vii. PubMed PMID: 12108831].
Weatherall DJ. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol 2011;154(6):736–44. doi: https://doi.org/10.1111/j.1365-2141.2011.08742.x [PubMed PMID: 21726207].
Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Bailliere’s Clin Haematol 1993;6(1):215–62. doi: https://doi.org/10.1016/S0950-3536(05)80071–X.
El-Hazmi MAF, Al-Hazmi AM, Warsy AS. Sickle cell disease in Middle East Arab countries. Indian J Med Res 2011;134(5):597–610. doi: https://doi.org/10.4103/0971–5916.90984 [PubMed PMID: PMC3249957].
Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and beta-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. J Epidemiol Global Health 2011;1(1):61–8. doi: https://doi.org/10.1016/j.jegh.2011.06.002.
Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and beta-thalassemia in Saudi Arabia. Ann Saudi Med 2011;31(3):229–35. doi: https://doi.org/10.4103/0256-4947.81527 [PubMed PMID: 21623050; PMCID: Pmc3119961].
Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ 2006;333(7573):831–4. doi: https://doi.org/10.1136/bmj.38982.704931.AE [PubMed PMID: 17053236; PMCID: Pmc1618440].
Saffi M, Howard N. Exploring the effectiveness of mandatory premarital screening and genetic counselling programmes for beta-thalassaemia in the middle east: a scoping review. Public Health Genomics 2015;18(4):193–203. doi: https://doi.org/10.1159/000430837 [PubMed PMID: 26045079].
Organization WH. Sickle-cell disease and other haemoglobin disorders 2011. Available from: http://www.who.int/mediacentre/factsheets/fs308/en/.
Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genetics Med 2007;9(6):372–7.
El-Hazmi MA. The natural history and the national pre-marital screening program in Saudi Arabia. Saudi Med J 2004;25(11):1549–54 [PubMed PMID: 15573176].
Health Mo. Overview of Premarital Screening 2014 [updated 08 April 201408 April 2014] MOH Portal Health Awareness Premarital Screening]. Available from: http://www.moh.gov.sa/en/HealthAwareness/Beforemarriage/Pages/default.aspx.
Al-Suliman A. Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia. Ann Saudi Med 2006;26(1):14–6 [PubMed PMID: 16521869].
Belhoul KM, Abdulrahman M, Alraei RF. Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results. Hemoglobin 2013;37(4):359–68. doi: https://doi.org/10.3109/03630269.2013.791627.
Alswaidi FM, Memish ZA, O’Brien SJ, Al-Hamdan NA, Al-Enzy FM, Alhayani OA, et al. At-risk marriages after compulsory premarital testing and counseling for beta-thalassemia and sickle cell disease in Saudi Arabia, 2005–2006. J Genetic Couns 2012;21(2):243–55. doi: https://doi.org/10.1007/s10897-011-9395-4.
Health Mo. Statistical Year Book. Saudi Arabia2014. 248 p.
Rothman KJ. Epidemiology: an introduction. USA: Oxford University Press; 2002.
Incebiyik A, Genc A, Hilali NG, Camuzcuoglu A, Camuzcuoglu H, Kilic A, et al. Prevalence of beta-thalassemia trait and abnormal hemoglobins in Sanliurfa Province in southeast Turkey. Hemoglobin 2014;38(6):402–4. doi: https://doi.org/10.3109/03630269.2014.978008.
Al-Awamy BH. Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies. Saudi Med J 2000;21(1):8–17 [PubMed PMID: 11533744].
Mehdi SR, Al Dahmash BA. A comparative study of hematological parameters of alpha and beta thalassemias in a high prevalence zone: Saudi Arabia. Indian J Human Genetics 2011;17(3):207–11. doi: https://doi.org/10.4103/0971-6866.92106 [PubMed PMID: 22345994; PMCID: PMC3276991].
Coleman M, Al-Zahrani MH, Coleman M, Hemingway J, Omar A, Stanton MC, et al. A country on the verge of malaria elimination-the Kingdom of Saudi Arabia. PLoS One 2014;9(9):e105980. doi: https://doi.org/10.1371/journal.pone.0105980 [PubMed PMID: 25250619; PMCID: PMC4175080].
Almalki M, Fitzgerald G, Clark M. Health care system in Saudi Arabia: an overview. East Mediterr Health J 2011;17(10):784–93.
Mitchell JJ, Capua A, Clow C, Scriver CR. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Am J Human Genetics 1996;59(4):793–8 [PubMed PMID: PMC1914789].
Bozkurt G. Results from the north cyprus thalassemia prevention program. Hemoglobin 2007;31(2):257–64. doi: https://doi.org/10.1080/03630260701297204.
Author information
Authors and Affiliations
Corresponding author
Additional information
Peer review under responsibility of Ministry of Health, Saudi Arabia.
Rights and permissions
This is an open access article under the CC BY-NC-ND license (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/).
About this article
Cite this article
Alsaeed, E.S., Farhat, G.N., Assiri, A.M. et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015. J Epidemiol Glob Health 7 (Suppl 1), S41–S47 (2017). https://doi.org/10.1016/j.jegh.2017.12.001
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jegh.2017.12.001